Han, Dayong,
Teng, Lei,
Wang, Xiaoxiong,
Zhen, Yunbo,
Chen, Xiaofeng,
Yang, Mingchun,
Gao, Ming,
Yang, Guang,
Han, Mingyang,
Wang, Ligang,
Xu, Jiajun,
Li, Yue,
Shumadalova, Alina,
Zhao, Shiguang (2022) the efficiency and
safety of srsenic trioxide in glioma patients. Objective: The arsenic trioxide has the potent
Deal, C,
Steelman, J,
Vlachopapadopoulou, E,
Stawerska, R,
Silverman, LA;,
Phillip, M,
Kim, HS,
Ko, CW,
Malievskiy, O,
Cara, JF,
Roland, CL,
Taylor, CT,
Valluri, SR,
Wajnrajch, MP,
Pastrak, A,
Miller, BS (2022) the efficacy and
safety of once-weekly somatrogon with once-daily somatropin in prepubertal children with
GHD
Onorato, EM,
Alamanni, F,
Muratori, M,
Smolka, G,
Wojakowski, W,
Pysz, P,
Zorinas, A,
Zakarkaite, D,
Eltchaninoff, H,
Litzer, PY,
Godart, F,
Calvert, P,
Christou, C,
Mussayev, A,
Missiroli, B,
Buzaev, I,
Curello, S,
Tesorio, T,
Bartorelli, AL (2022) leaks (PVLs) were enrolled at 21 sites in 10 countries.
Safety data were available for 137 patients, who
Mukhametov, U.F.,
Lyulin, S.V.,
Borzunov, D.Y.,
Gareev, I.F.,
Beylerli, O.A.,
Sufianov, A.A. (2022) methods of prevention and treatment of HO were discussed. Conclusion According to the FDA
safety database